150 related articles for article (PubMed ID: 22904683)
1. Identification of cell surface targets through meta-analysis of microarray data.
Haeberle H; Dudley JT; Liu JT; Butte AJ; Contag CH
Neoplasia; 2012 Jul; 14(7):666-9. PubMed ID: 22904683
[TBL] [Abstract][Full Text] [Related]
2. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
[TBL] [Abstract][Full Text] [Related]
3. Multiplex meta-analysis of medulloblastoma expression studies with external controls.
Morgan AA; Achrol AS; Li MD; Khatri PJ; Cheshier SH
Pac Symp Biocomput; 2014; ():99-109. PubMed ID: 24297537
[TBL] [Abstract][Full Text] [Related]
4. Identification of Hub Genes in Pediatric Medulloblastoma by Multiple-Microarray Analysis.
Huang P; Guo YD; Zhang HW
J Mol Neurosci; 2020 Apr; 70(4):522-531. PubMed ID: 31820345
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma.
Rickert D; Bartl J; Picard D; Bernardi F; Qin N; Lovino M; Puget S; Meyer FD; Mahoungou Koumba I; Beez T; Varlet P; Dufour C; Fischer U; Borkhardt A; Reifenberger G; Ayrault O; Remke M
Acta Neuropathol; 2021 Jun; 141(6):975-978. PubMed ID: 33866410
[No Abstract] [Full Text] [Related]
6. A molecular fingerprint for medulloblastoma.
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics Analysis of Key Genes and Pathways for Medulloblastoma as a Therapeutic Target.
Shaabanpour Aghamaleki F; Mollashahi B; Aghamohammadi N; Rostami N; Mazloumi Z; Mirzaei H; Moradi A; Sheikhpour M; Movafagh A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):221-227. PubMed ID: 30678435
[TBL] [Abstract][Full Text] [Related]
8. Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment.
Liang Y; Diehn M; Bollen AW; Israel MA; Gupta N
J Neurooncol; 2008 Jan; 86(2):133-41. PubMed ID: 17653508
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
10. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival.
Neben K; Korshunov A; Benner A; Wrobel G; Hahn M; Kokocinski F; Golanov A; Joos S; Lichter P
Cancer Res; 2004 May; 64(9):3103-11. PubMed ID: 15126347
[TBL] [Abstract][Full Text] [Related]
11. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.
Martins-da-Silva A; Baroni M; Salomão KB; das Chagas PF; Bonfim-Silva R; Geron L; Cruzeiro GAV; da Silva WA; Corrêa CAP; Carlotti CG; de Paula Queiroz RG; Marie SKN; Brandalise SR; Yunes JA; Scrideli CA; Valera ET; Tone LG
Cell Mol Neurobiol; 2023 Mar; 43(2):813-826. PubMed ID: 35366170
[TBL] [Abstract][Full Text] [Related]
12. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.
Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T
Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229
[TBL] [Abstract][Full Text] [Related]
13. Emerging treatments and gene expression profiling in high-risk medulloblastoma.
Sardi I; Cavalieri D; Massimino M
Paediatr Drugs; 2007; 9(2):81-96. PubMed ID: 17407364
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.
de Bont JM; Kros JM; Passier MM; Reddingius RE; Sillevis Smitt PA; Luider TM; den Boer ML; Pieters R
Neuro Oncol; 2008 Oct; 10(5):648-60. PubMed ID: 18577562
[TBL] [Abstract][Full Text] [Related]
15. A transcriptome-based classifier to determine molecular subtypes in medulloblastoma.
Rathi KS; Arif S; Koptyra M; Naqvi AS; Taylor DM; Storm PB; Resnick AC; Rokita JL; Raman P
PLoS Comput Biol; 2020 Oct; 16(10):e1008263. PubMed ID: 33119584
[TBL] [Abstract][Full Text] [Related]
16. PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma.
Burger MC; Brucker DP; Baumgarten P; Ronellenfitsch MW; Wanka C; Hasselblatt M; Eccles MR; Klingebiel T; Weller M; Rieger J; Mittelbronn M; Steinbach JP
Int J Oncol; 2012 Jul; 41(1):235-41. PubMed ID: 22552444
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma genomics in the modern molecular era.
Kumar R; Liu APY; Northcott PA
Brain Pathol; 2020 May; 30(3):679-690. PubMed ID: 31799776
[TBL] [Abstract][Full Text] [Related]
18. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.
Bezerra Salomão K; Cruzeiro GAV; Bonfim-Silva R; Geron L; Ramalho F; Pinto Saggioro F; Serafini LN; Antunes Moreno D; de Paula Queiroz RG; Dos Santos Aguiar S; Cardinalli I; Yunes JA; Brandalise SR; Brassesco MS; Scrideli CA; Gonzaga Tone L
J Neurooncol; 2018 Aug; 139(1):33-42. PubMed ID: 29582271
[TBL] [Abstract][Full Text] [Related]
19. Detection of lower levels of SNAP25 using multiple microarray systems and its functional significance in medulloblastoma.
Huang CJ; Lee CL; Liu CY; Huang SH; Hou JW; Chen YH; Chien CC; Ho CM; Lo WC; Hung KL
Int J Mol Med; 2017 May; 39(5):1195-1205. PubMed ID: 28339008
[TBL] [Abstract][Full Text] [Related]
20. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
